Benefit of the Oxygen Reserve Index for Control of Success of Preoxygenation in Adults
PRIORI
1 other identifier
observational
60
1 country
1
Brief Summary
Valuation of the probability for a correct detection of paO2 \< 100 mmHg and paO2 \> 200 mmHg using the Oxygen Reserve Index
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2019
CompletedFirst Posted
Study publicly available on registry
October 22, 2020
CompletedStudy Start
First participant enrolled
December 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2021
CompletedFebruary 15, 2022
February 1, 2022
6 months
May 31, 2019
February 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Validation of the probability for a correct detection of paO2 < 100 mmHg and paO2 > 200 mmHg using the Oxygen Reserve Index
As mentioned above
preoxygenation of 3 minutes
Secondary Outcomes (4)
Patient characteristics
48 hours
MAP
preoxygenation of 3 minutes
NIRS (Near-infrared spectroscopy)
preoxygenation of 3 minutes
PI
preoxygenation of 3 minutes
Eligibility Criteria
Adult awake patients for elective surgery with indication for an invasive arterial blood pressure measurement
You may qualify if:
- Indication of an elective surgery with invasive arterial blood pressure measurement in awake patients
- written informed consent
You may not qualify if:
- Emergency surgery
- Patients with expected difficult airway and indication for an awake fiberoptic intubation and therefore no need of preoxygenation
- no written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Johannes Gutenberg - Universität
Mainz, Rhineland-Palatinate, 55131, Germany
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 31, 2019
First Posted
October 22, 2020
Study Start
December 1, 2020
Primary Completion
June 1, 2021
Study Completion
July 1, 2021
Last Updated
February 15, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share